Bristol Myers Squibb Company

For 2004, a year that saw the shares of T. Rowe Price Group Inc. surge more than 31 percent, company chief executive George A. Roche received a more modest 21.7 percent bump in his compensation - just about all from performance bonuses. In short, a half-...

It was quite a party: Celebrity guests like Martha Stewart and Mick Jagger mingled with business tycoons around bowls of caviar in an art-adorned Soho loft. Some guests saw the December affair as emblematic of the host's generosity, and that it reflected...

Here is a chronology of events in the ImClone Systems Inc. case: 1986: Samuel D. Waksal founds biopharmaceutical company ImClone Systems Inc., begins operations in a converted shoe factory in Manhattan. The company focuses on immunology-based...

Age: 55. Born in Paris and moved with his family in the early 1950s to Dayton, Ohio. Residence: SoHo loft in Manhattan, two homes in the Hamptons, on Long Island. Career: Scientist and researcher, with a doctorate in immunobiology. Undergraduate and...

Maryland lawmakers are considering clamping down on the fancy meals, theater tickets and expensive trips lavished on doctors by pharmaceutical companies trying to persuade health care professionals to prescribe their medications. "The system bothers me,"...

FINALLY OVER: A decadelong patent infringement battle over blood thinner Plavix ends with generic drugmaker Apotex Corp. paying about $445 million to Bristol-Myers Squibb and Sanofi. They jointly sell the world's second-best-selling drug. GENERICS...

TRENTON, N.J. (AP) — Just three months before the world's second-best-selling drug gets U.S. generic competition, a generic company has paid nearly $445 million to finally end a decadelong, twist-filled patent infringement battle with two...

TRENTON, N.J. (AP) — An experimental anti-clotting drug that Merck & Co. is developing was found to increase risk of dangerous internal bleeding in a second study, meaning it's unlikely to achieve the blockbuster status once expected — if it's...

Global sales of key Bristol-Myers Squibb drugs in 2011's fourth quarter: Drug name Use                   2011    &#...

EARNINGS MISS: Bristol-Myers Squibb Co. posts fourth-quarter adjusted earnings of $906 million, or 53 cents a share, on sales of $5.45 billion, just below Wall Street forecasts. PROFIT FORECAST: The drugmaker forecast earnings per share of $1.90 to $2...

Pfizer Inc.'s fourth-quarter profit fell by half because it sold less Lipitor, the cholesterol fighter that's the biggest drug ever to go off patent, and took some one-time charges. The landing was softened by cuts in its sales force and other costs, but...

Thirteen major pharmaceutical companies, government groups and health charities will work together in a push to eliminate or control by 2020 10 tropical diseases that affect more than a billion people in poor countries. The partners, including the Bill &...